Born in Montreal but raised in the Lower Mainland of British Columbia, Dr. Garnis completed her undergraduate training at the University of British Columbia (UBC) in 2000. She immediately began her graduate studies at the BC Cancer Research Centre, her work focusing primarily on genomic alterations in oral and lung malignancies.
Upon completion of her PhD in 2005, Dr. Garnis moved to Boston to undertake post-doctoral research at MIT with Dr. Phil Sharp (Nobel Prize in Physiology or Medicine, 1993). Her work in Boston was primarily focused on understanding molecular mechanisms of alternative RNA splicing.
In 2008, Dr. Garnis returned to Vancouver. She is currently appointed as Associate Professor and Director of Research for the Division of Otolaryngology in the UBC Faculty of Medicine and as a Senior Scientist at the BC Cancer Research Centre.
Advisory Board members sometimes work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of PCF, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
PCF requires directors, officers and advisory board members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Cathie Garnis discloses the following relationships and financial interests:
University of British Columbia – Faculty
Canadian Institutes of Health Research (CIHR) – Operating Grants
National Patent Application
This page and data include information for a specific PCF annual disclosure form. This data reflects interests that may or may not still exist. This data is updated annually.